Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer
NCT ID: NCT06853730
Last Updated: 2025-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
654 participants
OBSERVATIONAL
2014-01-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Study of Ovarian Cancer Patients With Brain Metastasis
NCT01258881
A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
NCT05251883
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
NCT03614689
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573
Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis
NCT01268956
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-metastasis Group
This group consists of ovarian cancer patients without lymph node metastasis. By comparing with the metastasis group, we aim to identify the clinical factors that differentiate patients with and without metastasis.
No interventions assigned to this group
Metastasis Group
This group includes ovarian cancer patients with lymph node metastasis. We will analyze the clinical characteristics and metastasis pathways of these patients to identify clinical factors associated with metastasis.Based on the clinical factors (such as the location of the primary tumor, stage of cancer, etc.), we further subgroup the metastatic patients (e.g., based on the side of the primary tumor). This analysis aims to explore whether there are specific patterns or pathways of lymph node metastasis in these subgroups.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xu Huishan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xu Huishan
Research Assistant, Ovarian Cancer Study Group, Sun Yat-sen University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SYSU-LNM-OVCA01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.